Evidence map›Paper›PMID 41158481›Full record

ReviewERJ open research2025

Natural killer T-cells in asthma pathogenesis and treatment: old problems and future perspectives.

Akter Dilroba, Asia Fanella, Tommaso Pianigiani, Irene Paggi, Miriana d'Alessandro, Marco Saletti, Elena Bargagli, Paolo Cameli, Laura Bergantini

Abstract readReview
In one paragraph

Review in ERJ open research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akter DilrobaUOC Malattie dell'Apparato Respiratorio e del Trapianto di Polmone, University of Siena, Siena, Italy.
Asia FanellaUOC Malattie dell'Apparato Respiratorio e del Trapianto di Polmone, University of Siena, Siena, Italy.ORCID https://orcid.org/0009-0008-6172-9328
Tommaso PianigianiUOC Malattie dell'Apparato Respiratorio e del Trapianto di Polmone, University of Siena, Siena, Italy.
Irene PaggiUOC Malattie dell'Apparato Respiratorio e del Trapianto di Polmone, University of Siena, Siena, Italy.
Miriana d'AlessandroUOC Malattie dell'Apparato Respiratorio e del Trapianto di Polmone, University of Siena, Siena, Italy.
Marco SalettiDirettore UOSA Allergologia, Dipartimento di Scienze Mediche, University of Siena, Siena, Italy.
Elena BargagliUOC Malattie dell'Apparato Respiratorio e del Trapianto di Polmone, University of Siena, Siena, Italy.
Paolo CameliUOC Malattie dell'Apparato Respiratorio e del Trapianto di Polmone, University of Siena, Siena, Italy.
Laura BergantiniUOC Malattie dell'Apparato Respiratorio e del Trapianto di Polmone, University of Siena, Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer T-cells (NKT-cells) are immunological cells expressing features of both innate and adaptive immunity, which have been reported to be involved in the pathogenesis of asthma and in the induction of airway hyperresponsiveness (AHR). In this review we discuss the controversial results obtained in the past due to the lack of standardised analytical methods and the inhomogeneity of cohorts. In recent years, the availability of more advanced techniques led to a significant improvement in the phenotyping of these cells. Several research studies, both in mice and humans, reported that NKT-cells might be involved in the induction of AHR through the secretion of cytokines. In mouse models, in the absence of NKT-cells, AHR was not triggered and the airway eosinophil count was reduced. A relationship between NKT-cells and both innate (

Identifiers

PMID41158481
PMCPMC12557352

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.